AVIR
Atea Pharmaceuticals, Inc.
Atea Pharmaceuticals, Inc. (AVIR) has 15 SEC Form 4 filings (22 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jun 23, 2026.
- Industry:Biotechnology
- CEO:Jean-Pierre Sommadossi
- Employees:55
- HQ:Boston, MA, US
- IPO:2020-10-30
Insider Buying
$51K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$399.3M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Director | Purchase | 6,100 | $25K | May 21 | SEC ↗ | |
Murphy Polly A.First filing | Director | Purchase | 6,100 | $25K | May 20 | SEC ↗ |
Related companies
Atea Pharmaceuticals, Inc. is in the Healthcare sector.